LCD L35677: Infliximab — Palmetto GBA
Rheumatology
Government source· CMS / MACverify ↗HCPCS Level II code
Q5102 — Injection, infliximab, biosimilar, 10 mg
HCPCS Level IIVerified Sep 19, 2026
Medicare payment
—
No national Medicare fee schedule we hold prices Q5102. CMS fee schedules ↗
Code definition
Code
Q5102
Code system
HCPCS Level II
Full description
Injection, infliximab, biosimilar, 10 mg
Policy activity for HCPCS Q5102
CLV Intelligence is tracking 1 policy change that cite HCPCS Q5102 most recently on 2026-09-12, drawn from 1 LCD/NCD coverage update. The changes span Rheumatology.
- LCD/NCD coverage update
- 1
Counts reflect the source documents CLV has matched to HCPCS Q5102 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to Q5102
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Audit documentation
Building an audit file that includes HCPCS Q5102?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect Q5102
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Free — no account required
See what CLV monitors for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
90-day windowPDF sample reportInstant download
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy